66 related articles for article (PubMed ID: 16198400)
21. Knowledge of the cervical cancer screening process among rural and urban illinois women undergoing colposcopy.
Massad LS; Verhulst SJ; Hagemeyer M; Brady P
J Low Genit Tract Dis; 2006 Oct; 10(4):252-5. PubMed ID: 17012992
[TBL] [Abstract][Full Text] [Related]
22. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer screening in Thailand: an overview.
Sriamporn S; Khuhaprema T; Parkin M
J Med Screen; 2006; 13 Suppl 1():S39-43. PubMed ID: 17227641
[TBL] [Abstract][Full Text] [Related]
24. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
[TBL] [Abstract][Full Text] [Related]
25. Alternative cervical cancer prevention in low-resource settings: Experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand.
Palanuwong B
Aust N Z J Obstet Gynaecol; 2007 Feb; 47(1):54-60. PubMed ID: 17261102
[TBL] [Abstract][Full Text] [Related]
26. Hispanic acculturation and utilization of cervical cancer screening in the US.
Shah M; Zhu K; Wu H; Potter J
Prev Med; 2006 Feb; 42(2):146-9. PubMed ID: 16297444
[TBL] [Abstract][Full Text] [Related]
27. [Quality of the Early Cervical Cancer Detection Program in the State of Nuevo León].
Salinas-Martínez AM; Villarreal-Ríos E; Garza-Elizondo ME; Fraire-Gloria JM; López-Franco JJ; Barboza-Quintana O
Salud Publica Mex; 1997; 39(3):187-94. PubMed ID: 9304221
[TBL] [Abstract][Full Text] [Related]
28. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
29. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
[TBL] [Abstract][Full Text] [Related]
30. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
32. Screening history of women in Malmö with invasive cervical cancer.
Lindqvist PG; Hellsten C; Rippe A
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):77-83. PubMed ID: 17210219
[TBL] [Abstract][Full Text] [Related]
33. Organisation of cervical cytology screening in Croatia: past, present and future.
Pajtler M; Audy-Jurković S; Kardum-Skelin I; Mahovlić V; Mozetic-Vrdoljak D; Ovanin-Rakić A
Coll Antropol; 2007 Apr; 31 Suppl 2():47-54. PubMed ID: 17598505
[TBL] [Abstract][Full Text] [Related]
34. [Cervical cancer after 10 years of nationally coordinated screening].
Haldorsen T; Skare GB; Steen R; Thoresen SO
Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
[TBL] [Abstract][Full Text] [Related]
35. Current techniques in screening for cervical cancer in Spain: updated recommendations.
Puig-Tintoré LM; Torné A; Alonso I
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S8-S10. PubMed ID: 18606440
[TBL] [Abstract][Full Text] [Related]
36. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
37. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries.
Suba EJ
Clin Lab Med; 2004 Dec; 24(4):945-63. PubMed ID: 15555750
[TBL] [Abstract][Full Text] [Related]
38. Pap screening clinics with native women in Skidegate, Haida Gwaii. Need for innovation.
Calam B; Norgrove L; Brown D; Wilson MA
Can Fam Physician; 1999 Feb; 45():355-60. PubMed ID: 10065309
[TBL] [Abstract][Full Text] [Related]
39. External quality assurance for cervical cytology in developing countries. Experience in Peru and Nicaragua.
Salvetto M; Sandiford P
Acta Cytol; 2004; 48(1):23-31. PubMed ID: 14969177
[TBL] [Abstract][Full Text] [Related]
40. Health education and agency: a comprehensive program for young women in the Mixteca region of Mexico.
Venguer T; Pick S; Fishbein M
Psychol Health Med; 2007 Aug; 12(4):389-406. PubMed ID: 17620204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
